Search research articles
Contact Us
Filters
Showing results (181-190 of 321) with videos related to
Page
of 33
Sort By:
Vascular and Endovascular Surgery
|
June 27, 2009
Inflammatory abdominal aortic aneurysms (IAAA): past and present
Sharath C V Paravastu, David Murray, Jonathan Ghosh, et al.
Experimental Hematology
|
June 13, 2012
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines
Benigno C Valdez, Yago Nieto, David Murray, et al.
Journal of Graduate Medical Education
|
October 7, 2011
Creating and evaluating a data-driven curriculum for central venous catheter placement
James R Duncan, Katherine Henderson, Mandie Street, et al.
Leukemia & Lymphoma
|
April 11, 2017
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
Benigno C Valdez, Yang Li, David Murray, et al.
Acta Orthopaedica
|
June 24, 2014
The influence of hip rotation on femoral offset in plain radiographs
Philipp Lechler, Michael Frink, Aashish Gulati, et al.
Blood Advances
|
December 1, 2025
Engraftment of gene-edited hematopoietic stem cells after antibody-drug conjugate conditioning in nonhuman primates
Jason David Murray, Teresa K Einhaus, Stefan Radtke, et al.
Oncotarget
|
March 14, 2024
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells
Benigno C Valdez, Bin Yuan, David Murray, et al.
Oncotarget
|
February 10, 2018
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells
Benigno C Valdez, Yang Li, David Murray, et al.
Leukemia & Lymphoma
|
October 26, 2011
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines
Benigno C Valdez, David Murray, Yago Nieto, et al.
Public Health
|
September 11, 2007
Barriers to conducting research on breast screening: experience from a telephone survey with non-attenders in a UK inner city borough
Laidon Shapo, Anthony Kessel, Kerry Lee, et al.
Page
of 33
Search research articles
Search
Showing results (181-190 of 321) with videos related to
Sort By:
Page
of 33
Vascular and Endovascular Surgery
|
June 27, 2009
Inflammatory abdominal aortic aneurysms (IAAA): past and present
Sharath C V Paravastu, David Murray, Jonathan Ghosh, et al.
Experimental Hematology
|
June 13, 2012
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines
Benigno C Valdez, Yago Nieto, David Murray, et al.
Journal of Graduate Medical Education
|
October 7, 2011
Creating and evaluating a data-driven curriculum for central venous catheter placement
James R Duncan, Katherine Henderson, Mandie Street, et al.
Leukemia & Lymphoma
|
April 11, 2017
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
Benigno C Valdez, Yang Li, David Murray, et al.
Acta Orthopaedica
|
June 24, 2014
The influence of hip rotation on femoral offset in plain radiographs
Philipp Lechler, Michael Frink, Aashish Gulati, et al.
Blood Advances
|
December 1, 2025
Engraftment of gene-edited hematopoietic stem cells after antibody-drug conjugate conditioning in nonhuman primates
Jason David Murray, Teresa K Einhaus, Stefan Radtke, et al.
Oncotarget
|
March 14, 2024
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells
Benigno C Valdez, Bin Yuan, David Murray, et al.
Oncotarget
|
February 10, 2018
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells
Benigno C Valdez, Yang Li, David Murray, et al.
Leukemia & Lymphoma
|
October 26, 2011
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines
Benigno C Valdez, David Murray, Yago Nieto, et al.
Public Health
|
September 11, 2007
Barriers to conducting research on breast screening: experience from a telephone survey with non-attenders in a UK inner city borough
Laidon Shapo, Anthony Kessel, Kerry Lee, et al.
Page
of 33